-
1
Next-generation sequencing (NGS) is being explored for pathogen detection, outbreak investigation, and antimicrobial resistance surveillance in clinical microbiology.
-
2
Nanopore sequencing offers flexibility and long-read capabilities, improving pathogen characterization and integration into routine clinical workflows.
-
3
Implementation of nanopore sequencing in clinical laboratories is feasible, requiring expertise in laboratory-developed tests and robust validation processes.
-
4
NGS is unlikely to replace traditional methods but may complement them by enhancing sensitivity, specificity, and turnaround time in diagnostics.
-
5
Nanopore sequencing supports outbreak detection and public health surveillance by providing detailed genomic data for epidemiology and resistance monitoring.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
